Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

129,942 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lipopolysaccharide-induced active telocyte exosomes alleviate lipopolysaccharide-induced vascular barrier disruption and acute lung injury via the activation of the miRNA-146a-5p/caspase-3 signaling pathway in endothelial cells.
Huang X, Zhang H, Luo Y, Yi X, Zhou Z, Guo F, Yi L. Huang X, et al. Among authors: zhang h. Burns Trauma. 2025 Jan 14;13:tkae074. doi: 10.1093/burnst/tkae074. eCollection 2025. Burns Trauma. 2025. PMID: 39811430 Free PMC article.
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial.
Li Z, Li Z, Cheng X, Zhang H, Yang C, Xu Q, Chen Z, Zhen Y, Li G, Liu G, Yao W, Zhou M, Jin J, Huang J, Fang Y, Xie L, Poon MC, Wu R. Li Z, et al. Among authors: zhang h. Res Pract Thromb Haemost. 2024 Nov 28;9(1):102639. doi: 10.1016/j.rpth.2024.102639. eCollection 2025 Jan. Res Pract Thromb Haemost. 2024. PMID: 39810987 Free PMC article.
129,942 results
You have reached the last available page of results. Please see the User Guide for more information.